FR2556965B1 - Nouvelle forme galenique du ketoprofene a liberation controlee - Google Patents

Nouvelle forme galenique du ketoprofene a liberation controlee

Info

Publication number
FR2556965B1
FR2556965B1 FR8320470A FR8320470A FR2556965B1 FR 2556965 B1 FR2556965 B1 FR 2556965B1 FR 8320470 A FR8320470 A FR 8320470A FR 8320470 A FR8320470 A FR 8320470A FR 2556965 B1 FR2556965 B1 FR 2556965B1
Authority
FR
France
Prior art keywords
controlled release
galenic form
new galenic
release ketoprofen
ketoprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8320470A
Other languages
English (en)
Other versions
FR2556965A1 (fr
Inventor
Raymond Bentejac
Michel Veillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Priority to FR8320470A priority Critical patent/FR2556965B1/fr
Priority to JP59051310A priority patent/JPH0635383B2/ja
Priority to GB08431987A priority patent/GB2151921B/en
Publication of FR2556965A1 publication Critical patent/FR2556965A1/fr
Application granted granted Critical
Publication of FR2556965B1 publication Critical patent/FR2556965B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR8320470A 1983-12-21 1983-12-21 Nouvelle forme galenique du ketoprofene a liberation controlee Expired FR2556965B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR8320470A FR2556965B1 (fr) 1983-12-21 1983-12-21 Nouvelle forme galenique du ketoprofene a liberation controlee
JP59051310A JPH0635383B2 (ja) 1983-12-21 1984-03-19 ケトプロフエンの経口投与のための放出が制御された錠剤及びその製造方法
GB08431987A GB2151921B (en) 1983-12-21 1984-12-19 Controlled release form of ketoprofen for oral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8320470A FR2556965B1 (fr) 1983-12-21 1983-12-21 Nouvelle forme galenique du ketoprofene a liberation controlee

Publications (2)

Publication Number Publication Date
FR2556965A1 FR2556965A1 (fr) 1985-06-28
FR2556965B1 true FR2556965B1 (fr) 1986-08-22

Family

ID=9295398

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8320470A Expired FR2556965B1 (fr) 1983-12-21 1983-12-21 Nouvelle forme galenique du ketoprofene a liberation controlee

Country Status (3)

Country Link
JP (1) JPH0635383B2 (fr)
FR (1) FR2556965B1 (fr)
GB (1) GB2151921B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0212746B1 (fr) * 1985-08-16 1991-04-10 The Procter & Gamble Company Particules pour une libération constante de la substance active
DE3678641D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
GB8616669D0 (en) 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
EP0325086A3 (fr) * 1987-11-23 1990-10-31 Jago Research Ag Méthodes pour obtenir des systèmes thérapeutiques à libération contrôlée du médicament
JP2727009B2 (ja) * 1989-03-10 1998-03-11 ダイト株式会社 持続性製剤
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
CA1097220A (fr) * 1975-10-10 1981-03-10 Aaron L. Weiss Comprime a delitement progressif
EP0013131A3 (fr) * 1978-12-27 1981-01-07 Mundipharma A.G. Composition pharmaceutique sous forme de dosage solide et procédé pour sa fabrication
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
GB8431987D0 (en) 1985-01-30
FR2556965A1 (fr) 1985-06-28
GB2151921B (en) 1988-08-03
GB2151921A (en) 1985-07-31
JPH0635383B2 (ja) 1994-05-11
JPS60132915A (ja) 1985-07-16

Similar Documents

Publication Publication Date Title
FR2547498B1 (fr) Comprimes de naproxen et de naproxen sodique a liberation controlee
DOP1990004769A (es) Proceso para la preparacion de una modificacion de cristales
PT76873B (fr) Procede de preparation de compositions a liberation regulee d'action prolongee
FR2630637B1 (fr) Nouvelle prothese alveolaire
FR2514642B1 (fr) Compositions pharmaceutiques a liberation retardee
ES509164A0 (es) "un procedimiento para la preparacion de nuevos derivados de piperidina"
FR2565822B1 (fr) Nouvelle forme galenique retard
ES533474A0 (es) Procedimiento para modificar un elemento quirurgico estructural
FR2556965B1 (fr) Nouvelle forme galenique du ketoprofene a liberation controlee
FR2573307B1 (fr) Implants anabolisants a liberation prolongee
AT389251B (de) Kuehlung einer stranggiesskokille
ES537487A0 (es) Un procedimiento para la preparacion de oxazolidinas
ES533183A0 (es) Amoxicilina sodica cristalina
AU2916477A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
DK162144C (da) Fremgangsmaade til fremstilling af et krystallinsk silicat
BR8905385A (pt) Metodo para medir a potencia de uma lente
FR2692484B1 (fr) Nouvelle forme galenique de 4-asa a liberation controlee.
ES538606A0 (es) Un procedimiento para preparar una sustancia antibiotica seleccionada del antibiotico l 17054 y sus sales por adicion de acidos farmaceuticamente acepatables
IT1081440B (it) Impianto per l'avanzamento di una forma di colata
NO843352L (no) Estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater
ES548453A0 (es) Procedimiento para preparar derivados de acidos 16-fenoxi y 16(fenoxi sustituido)-prostatrienoicos y sus estereoisomeros
FR2542195B1 (fr) Nouvelle association medicamenteuse
FR2602086B1 (fr) Element expansible pour bobine d'allumage
MX162661A (es) Composicion a base de pirrolidona para la disolucion de metales a coeficientes elevados
AR241081A1 (es) Procedimiento para la preparacion de 5-(2-hidroxietil)-sulfonil-2-aminofenol (-eteres)

Legal Events

Date Code Title Description
CD Change of name or company name